Mike Polark
Stock Analyst at Baird
(3.49)
# 929
Out of 5,044 analysts
76
Total ratings
53.06%
Success rate
5.48%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Outperform | $180 → $220 | $182.84 | +20.32% | 9 | Oct 10, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $93.23 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $24.43 | -18.13% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $53.86 | +11.40% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $324.43 | +7.88% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $77.16 | +205.86% | 7 | May 6, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $27.98 | +3.65% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $82.23 | -27.03% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $257.39 | -30.07% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $101.12 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $375.84 | +7.76% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $545.00 | -7.71% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $126.63 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $130.68 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $69.33 | +74.53% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $15.11 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.57 | +50.88% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $146.40 | +12.70% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $100.99 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.57 | +23.05% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $5.04 | +316.67% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $241.23 | +3.64% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.58 | +2,613.62% | 1 | Sep 2, 2020 |
iRhythm Technologies
Oct 10, 2025
Maintains: Outperform
Price Target: $180 → $220
Current: $182.84
Upside: +20.32%
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $93.23
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $24.43
Upside: -18.13%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $53.86
Upside: +11.40%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $324.43
Upside: +7.88%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $77.16
Upside: +205.86%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $27.98
Upside: +3.65%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $82.23
Upside: -27.03%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $257.39
Upside: -30.07%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $101.12
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $375.84
Upside: +7.76%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $545.00
Upside: -7.71%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $126.63
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $130.68
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $69.33
Upside: +74.53%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $15.11
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.57
Upside: +50.88%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $146.40
Upside: +12.70%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $100.99
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $10.57
Upside: +23.05%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $5.04
Upside: +316.67%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $241.23
Upside: +3.64%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.58
Upside: +2,613.62%